Overview

Drotaverine in Dysmenorrhoea Treatment

Status:
Terminated

Trial end date:
2006-02-28

Target enrollment:

Participant gender:

Summary

The aim of the study is to show that the combination of drotaverine 80mg and ibuprofen 400 mg is more effective and as well-tolerated as ibuprofen 400 mg or drotaverine 80 mg administered alone, in the treatment of primary and secondary dysmenorrhoea.

Phase:

Phase 4

Details

Lead Sponsor:

Sanofi

Treatments:

Drotaverin
Ibuprofen
Papaverine